From http://projects.propublica.org/docdollars. © Copyright 2011 Pro Publica Inc.
GlaxoSmithKline
See all GlaxoSmithKline payments »
Glaxo, whose top products include Advair, Flovent, and Valtrex, is based in the United Kingdom. In January 2011, Glaxo said it was setting aside $3.4 billion to settle government investigations and products liability lawsuits related to its diabetes drug Avandia
Notable drugs
Augmentin (Bacterial infections), Avandia Products (Diabetes), Engerix/Fendrix/Havrix/Twinrix (Hepatitis vaccines), Flixotide/Flovent (Asthma, difficulty breating), Infanrix, Pediarix (Childhood vaccines), Relenza (Influenza), Seretide/Advair (Asthma, lung diseases), Valtrex (Herpes)
Payment Reports
2009 Q2-Q4
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $15,431,934 | $46,295,802 |
| Consulting | $1,459,432 | $4,378,297 |
| $16,891,366 | $50,674,099 |
2010 Q1-Q4
GlaxoSmithKline began reporting research payments in 2010.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $13,188,948 | $52,755,793 |
| Research | $7,122,217 | $28,488,866 |
| Consulting | $1,004,756 | $4,019,024 |
| $21,315,921 | $85,263,683 |
Payments by State
| Calif. | $16,399,761 |
| N.Y. | $13,144,490 |
| Texas | $11,379,209 |
| Fla. | $10,836,296 |
| Pa. | $6,853,641 |
| Tenn. | $6,038,387 |
| N.C. | $5,740,089 |
| N.J. | $5,282,859 |
| Ohio | $5,114,854 |
| Mich. | $4,870,214 |
| Ill. | $4,861,519 |
| Mass. | $3,972,331 |
| Md. | $3,917,271 |
| Mo. | $3,327,020 |
| Colo. | $3,277,933 |
| Ga. | $3,057,297 |
| Ariz. | $2,721,836 |
| Va. | $2,682,450 |
| Ala. | $2,552,273 |
| Ind. | $2,541,279 |
| S.C. | $2,538,019 |
| Ky. | $2,261,946 |
| Wash. | $2,001,820 |
| La. | $1,751,626 |
| Conn. | $1,712,052 |
| Nev. | $1,700,976 |
| Wis. | $1,659,832 |
| Ore. | $1,557,986 |
| Minn. | $1,539,364 |
| Okla. | $1,362,901 |
| Kan. | $1,123,247 |
| Neb. | $1,030,535 |
| Miss. | $1,030,488 |
| Utah | $1,009,012 |
| D.C. | $908,899 |
| Iowa | $783,904 |
| W.Va. | $754,820 |
| R.I. | $725,185 |
| Ark. | $722,555 |
| Idaho | $471,162 |
| Del. | $388,500 |
| N.H. | $344,263 |
| N.M. | $219,759 |
| Hawaii | $199,342 |
| Maine | $184,732 |
| Mont. | $160,200 |
| S.D. | $130,325 |
| Vt. | $98,353 |
| N.D. | $96,875 |
| Alaska | $58,975 |
| N/A | $54,835 |
| P.R. | $40,150 |
| Wyo. | $29,300 |